{"id":"https://openalex.org/W2002851265","doi":"https://doi.org/10.1158/0008-5472.can-13-3263","title":"Ganetespib and HSP90: Translating Preclinical Hypotheses into Clinical Promise","display_name":"Ganetespib and HSP90: Translating Preclinical Hypotheses into Clinical Promise","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-01","ids":{"openalex":"https://openalex.org/W2002851265","doi":"https://doi.org/10.1158/0008-5472.can-13-3263","mag":"2002851265","pmid":"https://pubmed.ncbi.nlm.nih.gov/24556722"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-13-3263","doi":"https://doi.org/10.1158/0008-5472.can-13-3263","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-13-3263","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2002851265"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057196078","display_name":"David A. Proia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David A. Proia","raw_affiliation_strings":["Authors' Affiliation: Synta Pharmaceuticals Corp., Lexington, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Synta Pharmaceuticals Corp., Lexington, Massachusetts","institution_ids":["https://openalex.org/I4210158135"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051935182","display_name":"Richard C. Bates","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158135","display_name":"Synta Pharmaceuticals (United States)","ror":"https://ror.org/00rkhrg48","country_code":"US","type":"company","lineage":["https://openalex.org/I4210158135"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard C. Bates","raw_affiliation_strings":["Authors' Affiliation: Synta Pharmaceuticals Corp., Lexington, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliation: Synta Pharmaceuticals Corp., Lexington, Massachusetts","institution_ids":["https://openalex.org/I4210158135"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5057196078"],"corresponding_institution_ids":["https://openalex.org/I4210158135"],"apc_list":null,"apc_paid":null,"fwci":1.4764,"has_fulltext":false,"cited_by_count":116,"citation_normalized_percentile":{"value":0.82738392,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"74","issue":"5","first_page":"1294","last_page":"1300"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10958","display_name":"Ultrasound and Hyperthermia Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ganetespib","display_name":"ganetespib","score":1.0},{"id":"https://openalex.org/keywords/hsp90-inhibitors","display_name":"Hsp90 inhibitors","score":0.9269999861717224},{"id":"https://openalex.org/keywords/hsp90","display_name":"HSP90","score":0.9819999933242798},{"id":"https://openalex.org/keywords/client-proteins","display_name":"client proteins","score":0.6470000147819519},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.5920000076293945},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8849999904632568},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7080000042915344},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8840000033378601},{"id":"https://openalex.org/keywords/oncogenic-signaling","display_name":"oncogenic signaling","score":0.6460000276565552},{"id":"https://openalex.org/keywords/preclinical-activity","display_name":"preclinical activity","score":0.46299999952316284},{"id":"https://openalex.org/keywords/clinical-drug-development","display_name":"clinical development","score":0.5360000133514404}],"concepts":[{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.453545480966568},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4419138431549072}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018841","descriptor_name":"HSP90 Heat-Shock Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018841","descriptor_name":"HSP90 Heat-Shock Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-13-3263","doi":"https://doi.org/10.1158/0008-5472.can-13-3263","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-13-3263","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:24556722","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24556722","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W1563031684","https://openalex.org/W1864827749","https://openalex.org/W1988219667","https://openalex.org/W1988533633","https://openalex.org/W2001999652","https://openalex.org/W2005100930","https://openalex.org/W2006564825","https://openalex.org/W2007106751","https://openalex.org/W2022234086","https://openalex.org/W2022531767","https://openalex.org/W2025584298","https://openalex.org/W2029446677","https://openalex.org/W2036237603","https://openalex.org/W2040317578","https://openalex.org/W2050654618","https://openalex.org/W2056693633","https://openalex.org/W2073761249","https://openalex.org/W2075805324","https://openalex.org/W2099516272","https://openalex.org/W2100370559","https://openalex.org/W2100541925","https://openalex.org/W2107270715","https://openalex.org/W2111361612","https://openalex.org/W2113523455","https://openalex.org/W2114032749","https://openalex.org/W2114621192","https://openalex.org/W2115527176","https://openalex.org/W2115647596","https://openalex.org/W2117501436","https://openalex.org/W2119351872","https://openalex.org/W2124705172","https://openalex.org/W2135925159","https://openalex.org/W2136245016","https://openalex.org/W2137132470","https://openalex.org/W2137374006","https://openalex.org/W2137603765","https://openalex.org/W2139728893","https://openalex.org/W2147847797","https://openalex.org/W2166999544","https://openalex.org/W2170144893","https://openalex.org/W2171708713","https://openalex.org/W2224577761","https://openalex.org/W2286032795","https://openalex.org/W4249825500","https://openalex.org/W4301159569","https://openalex.org/W6633659891","https://openalex.org/W6651789931","https://openalex.org/W6681898681"],"related_works":["https://openalex.org/W1692324497","https://openalex.org/W2014889446","https://openalex.org/W4323318157","https://openalex.org/W2057551889","https://openalex.org/W4240297643","https://openalex.org/W2064630223","https://openalex.org/W2110238297","https://openalex.org/W2137132470","https://openalex.org/W2983652478","https://openalex.org/W2098070947"],"abstract_inverted_index":{"As":[0],"with":[1],"many":[2],"physiologic":[3],"processes":[4],"that":[5],"become":[6],"subverted":[7],"during":[8],"tumorigenesis,":[9],"the":[10,39,75,92,109,121,130,153,176],"chaperoning":[11],"activity":[12,111],"of":[13,35,41,63,77,95,98,113,119,123,135,142,155],"heat":[14],"shock":[15],"protein":[16],"90":[17],"(HSP90)":[18],"is":[19,100],"often":[20],"exploited":[21],"by":[22],"cancer":[23,89,143],"cells":[24],"to":[25,50,102],"confer":[26],"aberrant":[27],"proliferative,":[28],"survival,":[29],"and/or":[30],"metastatic":[31],"potential.":[32],"Functional":[33],"inhibition":[34],"HSP90":[36,64,83,136,178],"results":[37],"in":[38,45,139,167],"degradation":[40],"its":[42],"client":[43,146],"proteins,":[44],"turn":[46],"providing":[47],"a":[48,115,140],"means":[49],"concomitantly":[51],"disrupt":[52],"multiple":[53,168],"oncogenic":[54],"signaling":[55],"cascades":[56],"through":[57],"one":[58],"molecular":[59],"target.":[60],"Pharmacologic":[61],"blockade":[62],"has,":[65],"therefore,":[66],"emerged":[67],"as":[68,175],"an":[69],"innovative":[70],"and":[71,91,133,159],"multifaceted":[72],"approach":[73],"for":[74,88,129],"development":[76],"new":[78],"antineoplastic":[79],"agents.":[80],"However,":[81],"no":[82],"inhibitors":[84],"are":[85],"currently":[86,180],"approved":[87],"therapy":[90],"full":[93],"promise":[94],"this":[96,173],"class":[97],"agents":[99],"yet":[101],"be":[103],"realized.":[104],"This":[105],"review":[106],"focuses":[107],"on":[108],"preclinical":[110],"profile":[112],"ganetespib,":[114],"potent":[116],"small-molecule":[117],"inhibitor":[118,179],"HSP90,":[120],"characterization":[122],"which":[124],"has":[125],"provided":[126],"important":[127],"frameworks":[128],"optimal":[131],"design":[132],"application":[134],"inhibitor-based":[137],"strategies":[138],"variety":[141],"types.":[144],"Beyond":[145],"protein-driven":[147],"tumors,":[148],"ganetespib":[149],"can":[150],"also":[151],"potentiate":[152],"effects":[154],"other":[156],"molecularly":[157],"targeted":[158],"standard-of-care":[160],"therapeutics":[161],"while":[162],"simultaneously":[163],"overcoming":[164],"drug":[165],"resistance":[166],"tumor":[169],"types,":[170],"thereby":[171],"positioning":[172],"compound":[174],"leading":[177],"under":[181],"clinical":[182],"development.":[183]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2002851265","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":25},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
